Cervical Cancer Vaccine, Developed by Serum Institute of India And Dept of Biotechnology, to be launched on September 1, Say Sources
Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age.
Serum Institute of India and Department of Biotechnology plans to launch its indigenously-developed vaccine to treat cervical cancer in women on September 1, according to sources. It is worth noting that SII's qHPV vaccine got market authorisation from the Drugs Controller General of India(DCGI) on 12 July. Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age.
Check Tweet:
Serum Institute of India (SII) and Department of Biotechnology (DBT) to launch the indigenously developed India's first Quadrivalent Human Papillomavirus Vaccine (qHPV) against Cervical Cancer on Sept 1: Official Sources
— ANI (@ANI) August 31, 2022
(The above story first appeared on LatestLY on Aug 31, 2022 10:46 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
